Integrated Quantitative Investments LLC Takes Position in Molina Healthcare, Inc. (NYSE:MOH)

Integrated Quantitative Investments LLC purchased a new position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,000 shares of the company's stock, valued at approximately $291,000.

Other institutional investors have also recently made changes to their positions in the company. Versant Capital Management Inc increased its stake in Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after acquiring an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. acquired a new stake in shares of Molina Healthcare during the 4th quarter worth about $52,000. EverSource Wealth Advisors LLC raised its holdings in Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after buying an additional 88 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its position in Molina Healthcare by 337.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock valued at $58,000 after buying an additional 155 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd lifted its position in Molina Healthcare by 895.0% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock valued at $58,000 after buying an additional 179 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Insider Activity

In other news, Director Steven J. Orlando sold 1,000 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares in the company, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.10% of the company's stock.

Remove Ads

Molina Healthcare Stock Up 0.8 %

NYSE MOH traded up $2.62 on Friday, hitting $345.30. 661,970 shares of the stock were exchanged, compared to its average volume of 653,643. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $378.92. The company has a 50-day moving average price of $310.39 and a 200-day moving average price of $308.18. The company has a market cap of $18.89 billion, a PE ratio of 16.90, a PEG ratio of 1.06 and a beta of 0.70. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Sell-side analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on MOH shares. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $350.00 price target (down from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Barclays cut their target price on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research report on Friday, February 7th. Guggenheim started coverage on Molina Healthcare in a research report on Wednesday. They set a "neutral" rating for the company. UBS Group dropped their price objective on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Finally, StockNews.com raised Molina Healthcare from a "hold" rating to a "buy" rating in a research note on Friday. Seven research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $355.75.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.